David S. Briones
CIK 1599831 · Chief Financial Officer · last filed 2025-05-15
David S. Briones is a Chief Financial Officer who has filed 4 SEC Form 4 insider transactions across 2 companies since 2019.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
4
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZyVersa Therapeutics, Inc. (LSPRW) Delisted | Chief Financial Officer | 10,752 | $0.18 | $1.9K | $0 | 1 | 2022-03-10 |
| HOTH | Chief Financial Officer | — | $1.36 | — | $0 | 1 | 2019-03-07 |
Recent Filings
4 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-15 | — | Disp (D) | −20,000 | -$716.1K | |
| 2022-03-10 | ZyVersa Therapeutics, Inc. (LSPRW) Delisted | Other (J) | +10,752 | $0 | EDGAR |
| 2019-03-07 | HOTH | Other (J) | — | $0 | EDGAR |
| 2014-02-21 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.